Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression

Journal of Biological Chemistry

Volumn 290, Issue 25, 2015, Pages 15758-15769

  Tholen, Martina ^a   Wolanski, Julia ^a   Stolze, Britta ^a   Chiabudini, Marco ^a   Gajda, Mieczyslaw ^b   Bronsert, Peter ^c,d   Stickeler, Elmar ^c,d   Rospert, Sabine ^a   Reinheckel, Thomas ^a,d  

^a UNIVERSITY OF FREIBURG   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; BIOLOGICAL ORGANS; CELL CULTURE; CELLS; MAMMALS; PATHOLOGY; TUMORS;

EXPRESSION LEVELS; HUMAN BREAST CANCER; HUMAN BREAST CANCER CELLS; HUMAN CANCER CELLS; INTERNAL RIBOSOMAL ENTRY SITES; INTRINSIC RESISTANCE; TUMOR PROGRESSIONS; UNTRANSLATED REGIONS;

DISEASES;

CATHEPSIN L; MESSENGER RNA; 5' UNTRANSLATED REGION; CTSL PROTEIN, MOUSE; CTSL1 PROTEIN, HUMAN; RNA;

5' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CELL LINE; CANCER GROWTH; CARCINOGENESIS; CONTROLLED STUDY; CTSL GENE; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; INTERNAL RIBOSOME ENTRY SITE; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RNA SPLICING; RNA TRANSLATION; TRANSGENE; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; GENETICS; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGICAL STRESS; PROTEIN SYNTHESIS; SECONDARY; TRANSGENIC MOUSE; TUMOR CELL LINE;

MUS MUSCULUS;

5' UNTRANSLATED REGIONS; ANIMALS; BREAST NEOPLASMS; CATHEPSIN L; CELL LINE, TUMOR; FEMALE; HUMANS; LUNG NEOPLASMS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; NEOPLASM METASTASIS; PROTEIN BIOSYNTHESIS; RNA, NEOPLASM; STRESS, PHYSIOLOGICAL;

EID: 84940042815     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.624353     Document Type: Article

References (47)

1. Mason, S. D., and Joyce, J. A. (2011) Proteolytic networks in cancer. Trends Cell Biol. 21, 228-237
2. Nouh, M. A., Mohamed, M. M., El-Shinawi, M., Shaalan, M. A., Cavallo-Medved, D., Khaled, H. M., and Sloane, B. F. (2011) Cathepsin B: a potential prognostic marker for inflammatory breast cancer. J. Transl. Med. 9, 1
3. Miyamoto, K., Iwadate, M., Yanagisawa, Y., Ito, E., Imai, J., Yamamoto, M., Sawada, N., Saito, M., Suzuki, S., Nakamura, I., Ohki, S., Saze, Z., Kogure, M., Gotoh, M., Omicronbara, K., Ohira, H., Tasaki, K., Abe, M., Goshima, N., Watanabe, S., Waguri, S., and Takenoshita, S. (2011) Cathepsin L is highly expressed in gastrointestinal stromal tumors. Int. J. Oncol. 39, 1109-1115
4. Skrzypczak, M., Springwald, A., Lattrich, C., Häring, J., Schüler, S., Ortmann, O., and Treeck, O. (2012) Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes. Cancer Invest. 30, 398-403
5. Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C., Hanahan, D., and Joyce, J. A. (2006) Distinct roles for cysteine cathepsin genes in multistage tumorigenesis. Genes Dev. 20, 543-556
6. Harbeck, N., Alt, U., Berger, U., Krüger, A., Thomssen, C., Jänicke, F., Höfler, H., Kates, R. E., and Schmitt, M. (2001) Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy. Clin. Cancer Res. 7, 2757-2764
7. Foekens, J. A., Kos, J., Peters, H. A., Krasovec, M., Look, M. P., Cimerman, N., Meijer-van Gelder, M. E., Henzen-Logmans, S. C., van Putten, W. L., and Klijn, J. G. (1998) Prognostic significance of cathepsins B and L in primary human breast cancer. J. Clin. Oncol. 16, 1013-1021
8. Levicar, N., Kos, J., Blejec, A., Golouh, R., Vrhovec, I., Frkovic-Grazio, S., and Lah, T. T. (2002) Comparison of potential biological markers cathepsin B, cathepsin L, stefin A and stefin B with urokinase and plasminogen activator inhibitor-1 and clinicopathological data of breast carcinoma patients. Cancer Detect. Prev. 26, 42-49
9. Thomssen, C., Schmitt, M., Goretzki, L., Oppelt, P., Pache, L., Dettmar, P., Jänicke, F., and Graeff, H. (1995) Prognostic value of the cysteine proteases cathepsins B and cathepsin L in human breast cancer. Clin. Cancer Res. 1, 741-746
10. Rafn, B., Nielsen, C. F., Andersen, S. H., Szyniarowski, P., Corcelle-Termeau, E., Valo, E., Fehrenbacher, N., Olsen, C. J., Daugaard, M., Egebjerg, C., Bøttzauw, T., Kohonen, P., Nylandsted, J., Hautaniemi, S., Moreira, J., Jäättelä, M., and Kallunki, T. (2012) ErbB2-driven breast cancer cell invasion depends on a complex signaling network activating myeloid zinc finger-1-dependent cathepsin B expression. Mol. Cell 45, 764-776
11. Jean, D., Rousselet, N., and Frade, R. (2006) Expression of cathepsin L in human tumor cells is under the control of distinct regulatory mechanisms. Oncogene 25, 1474-1484
12. Samaiya, M., Bakhshi, S., Shukla, A. A., Kumar, L., and Chauhan, S. S. (2011) Epigenetic regulation of cathepsin L expression in chronic myeloid leukaemia. J. Cell Mol. Med. 15, 2189-2199
13. Zajc, I., Sever, N., Bervar, A., and Lah, T. T. (2002) Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines. Cancer Lett. 187, 185-190
14. Rescheleit, D. K., Rommerskirch, W. J., and Wiederanders, B. (1996) Sequence analysis and distribution of two new human cathepsin L splice variants. FEBS Lett. 394, 345-348
15. Abudula, A., Rommerskirch, W., Weber, E., Günther, D., and Wiederanders, B. (2001) Splice variants of human cathepsin L mRNA show different expression rates. Biol. Chem. 382, 1583-1591
16. Mittal, S., Mir, R. A., and Chauhan, S. S. (2011) Post-transcriptional regulation of human cathepsin L expression. Biol. Chem. 392, 405-413
17. Spriggs, K. A., Bushell, M., and Willis, A. E. (2010) Translational regulation of gene expression during conditions of cell stress. Mol. Cell 40, 228-237
18. Silvera, D., Formenti, S. C., and Schneider, R. J. (2010) Translational control in cancer. Nat. Rev. Cancer 10, 254-266
19. Mamane, Y., Petroulakis, E., LeBacquer, O., and Sonenberg, N. (2006) mTOR, translation initiation and cancer. Oncogene 25, 6416-6422
20. Spriggs, K. A., Stoneley, M., Bushell, M., and Willis, A. E. (2008) Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol. Cell 100, 27-38
21. Jean, D., Rousselet, N., and Frade, R. (2008) Cathepsin L expression is up-regulated by hypoxia in human melanoma cells: role of its 5′-untranslated region. Biochem. J. 413, 125-134
22. Gilbert, W. V. (2010) Alternative ways to think about cellular internal ribosome entry. J. Biol. Chem. 285, 29033-29038
23. Kozak, M. (2005) A second look at cellular mRNA sequences said to function as internal ribosome entry sites. Nucleic Acids Res. 33, 6593-6602
24. Shatsky, I. N., Dmitriev, S. E., Terenin, I. M., and Andreev, D. E. (2010) Cap- and IRES-independent scanning mechanism of translation initiation as an alternative to the concept of cellular IRESs. Mol. Cells 30, 285-293
25. Houseweart, M. K., Pennacchio, L. A., Vilaythong, A., Peters, C., Noebels, J. L., and Myers, R. M. (2003) Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1). J. Neurobiol. 56, 315-327
26. Guy, C. T., Cardiff, R. D., and Muller, W. J. (1992) Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell Biol. 12, 954-961
27. Vasiljeva, O., Korovin, M., Gajda, M., Brodoefel, H., Bojic, L., Krüger, A., Schurigt, U., Sevenich, L., Turk, B., Peters, C., and Reinheckel, T. (2008) Reduced tumour cell proliferation and delayed development of high-grade mammary carcinomas in cathepsin B-deficient mice. Oncogene 27, 4191-4199
28. Bengsch, F., Buck, A., Günther, S. C., Seiz, J. R., Tacke, M., Pfeifer, D., von Elverfeldt, D., Sevenich, L., Hillebrand, L. E., Kern, U., Sameni, M., Peters, C., Sloane, B. F., and Reinheckel, T. (2014) Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression. Oncogene 33, 4474-4484
29. Lin, E. Y., Jones, J. G., Li, P., Zhu, L., Whitney, K. D., Muller, W. J., and Pollard, J. W. (2003) Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol. 163, 2113-2126
30. Sevenich, L., Pennacchio, L. A., Peters, C., and Reinheckel, T. (2006) Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice. Biol. Chem. 387, 885-891
31. Esposito, A. M., Mateyak, M., He, D., Lewis, M., Sasikumar, A. N., Hutton, J., Copeland, P. R., and Kinzy, T. G. (2010) Eukaryotic polyribosome profile analysis. J. Vis. Exp. 40, 1948
32. Thoreen, C. C., and Sabatini, D. M. (2009) Rapamycin inhibits mTORC1, but not completely. Autophagy 5, 725-726
33. Caserman, S., Kenig, S., Sloane, B. F., and Lah, T. T. (2006) Cathepsin L splice variants in human breast cell lines. Biol. Chem. 387, 629-634
34. Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., and Massagué, J. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436, 518-524
35. Chang, T. H., Huang, H. Y., Hsu, J. B., Weng, S. L., Horng, J. T., and Huang, H. D. (2013) An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinformatics 14, S4
36. Buchan, J. R., and Parker, R. (2009) Eukaryotic stress granules: the ins and outs of translation. Mol. Cell 36, 932-941
37. Ivanov, P. A., Chudinova, E. M., and Nadezhdina, E. S. (2003) Disruption of microtubules inhibits cytoplasmic ribonucleoprotein stress granule formation. Exp. Cell Res. 290, 227-233
38. Mohamed, M. M., and Sloane, B. F. (2006) Cysteine cathepsins: multifunctional enzymes in cancer. Nat. Rev. Cancer 6, 764-775
39. Dennemärker, J., Lohmüller, T., Müller, S., Aguilar, S. V., Tobin, D. J., Peters, C., and Reinheckel, T. (2010) Impaired turnover of autophagolysosomes in cathepsin L deficiency. Biol. Chem. 391, 913-922
40. Young, R. M., Wang, S. J., Gordan, J. D., Ji, X., Liebhaber, S. A., and Simon, M. C. (2008) Hypoxia-mediated selective mRNA translation by an internal ribosome entry site-independent mechanism. J. Biol. Chem. 283, 16309-16319
41. Piccirillo, C. A., Bjur, E., Topisirovic, I., Sonenberg, N., and Larsson, O. (2014) Translational control of immune responses: from transcripts to translatomes. Nat. Immunol. 15, 503-511
42. Unsworth, H., Raguz, S., Edwards, H. J., Higgins, C. F., and Yagüe, E. (2010) mRNA escape from stress granule sequestration is dictated by localization to the endoplasmic reticulum. FASEB J. 24, 3370-3380
43. Reid, D. W., and Nicchitta, C. V. (2012) Primary role for endoplasmic reticulum-bound ribosomes in cellular translation identified by ribosome profiling. J. Biol. Chem. 287, 5518-5527
44. Ivanov, P., Kedersha, N., and Anderson, P. (2011) Stress puts TIA on TOP. Genes Dev. 25, 2119-2124
45. Wilkinson, N., and Pantopoulos, K. (2014) The IRP/IRE system in vivo: insights from mouse models. Front. Pharmacol. 5, 176
46. Meng, X., Zhu, D., Yang, S., Wang, X., Xiong, Z., Zhang, Y., Brachova, P., and Leslie, K. K. (2012) Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein. J. Biol. Chem. 287, 4485-4491
47. Noch, E., Bookland, M., and Khalili, K. (2011) Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma. Cancer Biol. Ther. 11, 32-39